In summary, EGCG may serve a role in preventing obesity-related precocious puberty through targets such as AKT1, EGFR, ESR1, STAT3, IGF1, and MAPK1 that acted on multiple signaling pathways, including the estrogen, PI3K-Akt, MAPK, and Jak-STAT pathways. The gene discussed is MAPK1; the disease is obesity disorder.